OMT 28

Drug Profile

OMT 28

Alternative Names: OMT-28

Latest Information Update: 27 Nov 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator OMEICOS Therapeutics
  • Class Antiarrhythmics; Cardiovascular therapies; Eicosanoids; Omega 3 fatty acids; Small molecules
  • Mechanism of Action Peroxisome proliferator-activated receptor alpha agonists; Sirtuin stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Phase I Atrial fibrillation
  • Preclinical Myocardial infarction

Most Recent Events

  • 15 Nov 2017 Preclinical data in Atrial fibrillation presented at the 90th Annual Scientific Sessions of the American Heart Association (AHA-2017)
  • 01 Jun 2017 Preclinical trials in Myocardial infarction in Germany (PO)
  • 01 Mar 2017 Phase-I clinical trials in Atrial fibrillation in Germany (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top